BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Naing C, Mak JW, Ahmed SI, Maung M. Relationship between hepatitis C virus infection and type 2 diabetes mellitus: Meta-analysis. World J Gastroenterol 2012; 18(14): 1642-1651 [PMID: 22529694 DOI: 10.3748/wjg.v18.i14.1642]
URL: https://www.wjgnet.com/1007-9327/full/v18/i14/1642.htm
Number Citing Articles
1
Sintayehu Ambachew, Setegn Eshetie, Demeke Geremew, Aklilu Endalamaw, Mulugeta Melku. Prevalence of type 2 diabetes mellitus among hepatitis C virus-infected patients: a protocol for systematic review and meta-analysisSystematic Reviews 2019; 8(1) doi: 10.1186/s13643-019-0976-x
2
Bouharati Khaoula, Bouharati Imene, Guenifi Wahiba, Gasmi Abdelkader, Laouamri Slimane. Intelligent Analysis of Some Factors Accompanying Hepatitis BMOLECULAR SCIENCES AND APPLICATIONS 2022; 2: 61 doi: 10.37394/232023.2022.2.7
3
Yujin Ding, Guangdi Li, Zhiguang Zhou, Tuo Deng. Molecular mechanisms underlying hepatitis C virus infection-related diabetesMetabolism 2021; 121: 154802 doi: 10.1016/j.metabol.2021.154802
4
Man-Huei Chang, Gloria L. Beckles, Ramal Moonesinghe, Benedict I. Truman. County-Level Socioeconomic Disparities in Use of Medical Services for Management of Infections by Medicare Beneficiaries With Diabetes—United States, 2012Journal of Public Health Management and Practice 2019; 25(4): E44 doi: 10.1097/PHH.0000000000000800
5
Dalia E. Desouky, Zaynab Kasemy, Alaa E. Abdel-Hamid, Mohamed S. Omar. Insulin Resistance and Prediabetes in Hepatitis C Virus PatientsThe American Journal of the Medical Sciences 2015; 350(2): 77 doi: 10.1097/MAJ.0000000000000513
6
Lawrence Serfaty. Metabolic Manifestations of Hepatitis C VirusClinics in Liver Disease 2017; 21(3): 475 doi: 10.1016/j.cld.2017.03.004
7
Mahmoud Abdo, Ahmed Rabiee, Zeinab Abdellatif, Shereen Abdel Alem, Ahmed Moustafa. Impact of sustained virological response on metabolic disorders in diabetic chronic hepatitis C virus patients after treatment with generic sofosbuvir and daclatasvirEuropean Journal of Gastroenterology & Hepatology 2021; 33(12): 1588 doi: 10.1097/MEG.0000000000001903
8
Cliviany Borges da Silva, Diego Alves Vieira, Luisa Freitas de Melo, Anna Luiza Soares Chagas, Adriana Dias Gomes, César Lúcio Lopes de Faria Jr, Rosângela Teixeira, Dulciene Maria de Magalhães Queiroz, Gifone Aguiar Rocha, Maria Marta Sarquis Soares, Juliana Maria Trindade Bezerra, Luciana Diniz Silva. Interleukin-6-174G/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virusWorld Journal of Hepatology 2020; 12(4): 137-148 doi: 10.4254/wjh.v12.i4.137
9
Bahawal Sana, Abdul Manan, Huma Khan, Muhammad Amjad Bashir, Muhammad Shahid Nisar, Khizer Samiullah, Irum Aziz, Muhammad Farooq, Asma Noreen, Talat Bilal Yasoob, Afrah Fahad Alkhuriji, Nawal M. Al-Malahi, Abdulrahman Alasmari, Mohammed Ali Alshehri, Munaza Batool, Awais Amjad, Sagheer Atta. A demographic study on causes of hepatitis transitions among the agricultural communityJournal of King Saud University - Science 2022; 34(5): 102085 doi: 10.1016/j.jksus.2022.102085
10
Mohammed J. Saeed, Margaret A. Olsen, William G. Powderly, Rachel M. Presti. Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C PatientsJournal of Clinical Gastroenterology 2017; 51(1): 70 doi: 10.1097/MCG.0000000000000566
11
Giacomo Gastaldi, Nicolas Goossens, Sophie Clément, Francesco Negro. Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: A reviewJournal of Advanced Research 2017; 8(2): 149 doi: 10.1016/j.jare.2016.11.003
12
Raghda N. Marzaban, Hesham I. AlMekhzangy, Wafaa ElAkel, Tamer M ElBaz, Yehia M. ElShazly, Kadry ElSaeed, Mahmoud Anees, Mohamed Said, Magdy A. ElSerafy, Gamal G. Esmat, Wahid H. Doss. Diabetic patients with chronic hepatitis C virus response compared to non diabetics when treated with directly acting antiviral therapyArab Journal of Gastroenterology 2024;  doi: 10.1016/j.ajg.2023.12.006
13
Giorgio Maria Saracco, Alfredo Marzano, Mario Rizzetto. Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?Biomedicines 2022; 10(3): 534 doi: 10.3390/biomedicines10030534
14
Palaniappan Manickam, Estela Mogrovejo, Rajesh Krishnamoorthi. HIV/Hepatitis C Virus-Coinfected Patients: Is There a Better Marker for Atherogenicity?AIDS Research and Human Retroviruses 2013; 29(5): 745 doi: 10.1089/aid.2012.0366
15
Cho Naing, Joon Wah Mak, Nyunt Wai, Mala Maung. Diabetes and Infections-Hepatitis C: Is There Type 2 Diabetes Excess in Hepatitis C Infection?Current Diabetes Reports 2013; 13(3): 428 doi: 10.1007/s11892-013-0370-3
16
Eva M. Teegen, Michael Dürr, Max M. Maurer, Franziska Eurich, Antonia Vollbort, Brigitta Globke, Marcus Bahra, Hendrik Blaeker, Johann Pratschke, Dennis Eurich. Evaluation of histological dynamics, kidney function and diabetes in liver transplant patients after antiviral treatment with direct‐acting antivirals: Therapy of HCV‐recurrenceTransplant Infectious Disease 2019; 21(1) doi: 10.1111/tid.13020
17
Livia Melo Villar, Bruno Geloneze, Ana Carolina Junqueira Vasques, Maria Lucia Elias Pires, Juliana Custódio Miguel, Elisangela Ferreira da Silva, Vanessa Alves Marques, Leticia de Paula Scalioni, Elisabeth Lampe, Motoyuki Otsuka. Prevalence of hepatitis B and hepatitis C among diabetes mellitus type 2 individualsPLOS ONE 2019; 14(2): e0211193 doi: 10.1371/journal.pone.0211193
18
Marian-Sorin Popescu, Dan-Mihai Firu, Vlad Pădureanu, Cristina Maria Mărginean, Radu Mitruț, Andreea Letitia Arsene, Dragoș Nicolae Mărgăritescu, Daniela Calina, Anca Oana Docea, Paul Mitruț. Effects of Achieving Sustained Virologic Response after Direct-Acting Antiviral Agents on Long-Term Liver Fibrosis in Diabetics vs. in Non-Diabetic Patients with Chronic Hepatitis C InfectionBiomedicines 2022; 10(9): 2093 doi: 10.3390/biomedicines10092093
19
Muhammad Sadik Memon, Zain Islam Arain, Farukh Naz, Madiha Zaki, Suresh Kumar, Asif Ali Burney. Prevalence of Type 2 Diabetes Mellitus in Hepatitis C Virus Infected Population: A Southeast Asian StudyJournal of Diabetes Research 2013; 2013: 1 doi: 10.1155/2013/539361
20
James A. Ndako, Akinyomade O. Owolabi, Joseph A. Olisa, Jeremiah A. Akinwumi, Victor T. Dojumo, Oludolapo Olatinsu, Blessing A. Adebayo. Studies on the prevalence of Hepatitis C virus infection in diabetic patients attending a tertiary health-care facility South-west NigeriaBMC Infectious Diseases 2020; 20(1) doi: 10.1186/s12879-020-05388-7
21
Prashant Pandya, Chaitanya Pant, Ryan Taylor, Olurinde Oni. Impact of Sustained Virological Response to Chronic Hepatitic C Antiviral Therapy on New Onset Diabetes Mellitus Type 2 after Controlling for Metabolic SyndromeJournal of Investigative Medicine 2017; 65(4): 765 doi: 10.1136/jim-2016-000343
22
Ying Chen, Hanzhen Ji, Jianguo Shao, Yulong Jia, Qi Bao, Jianan Zhu, Lei Zhang, Yi Shen. Different Hepatitis C Virus Infection Statuses Show a Significant Risk of Developing Type 2 Diabetes Mellitus: A Network Meta-AnalysisDigestive Diseases and Sciences 2020; 65(7): 1940 doi: 10.1007/s10620-019-05918-7
23
L Montenegro, A De Michina, G Misciagna, V Guerra, A Di Leo. Virus C Hepatitis and Type 2 Diabetes: A Cohort Study in Southern ItalyAmerican Journal of Gastroenterology 2013; 108(7): 1108 doi: 10.1038/ajg.2013.90
24
W-P Koh, R Wang, A Jin, M C Yu, J-M Yuan. Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health StudyBritish Journal of Cancer 2013; 108(5): 1182 doi: 10.1038/bjc.2013.25
25
Sylvia Drazilova, Jakub Gazda, Martin Janicko, Peter Jarcuska. Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA TherapyCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6150861
26
Huseyin Korkmaz, Recep Kesli, Barıs Onder Pamuk, Suleyman Hilmi Ipekci, Yuksel Terzi, Levent Kebapcilar. Assessment of Evidence for Positive Association and Seroprevalence of Hepatitis B and C in Diabetic Patients in a Developing CountryJournal of Investigative Medicine 2015; 63(2): 251 doi: 10.1097/JIM.0000000000000126
27
Mike Makris, Geoffrey Dusheiko. Viral Hepatitis2013; : 486 doi: 10.1002/9781118637272.ch35
28
C. Schnier, S. Wild, Z. Kurdi, C. Povey, D. J. Goldberg, S. J. Hutchinson. Matched population‐based study examining the risk of type 2 diabetes in people with and without diagnosed hepatitis C virus infectionJournal of Viral Hepatitis 2016; 23(8): 596 doi: 10.1111/jvh.12520
29
Boyoung Park, Kyu-Won Jung, Chang-Mo Oh, Kui Son Choi, Mina Suh, Jae Kwan Jun. Prevalence of and Factors Influencing Impaired Glucose Tolerance Among Hepatitis B CarriersMedicine 2014; 93(20): e91 doi: 10.1097/MD.0000000000000091
30
Ting‐Shuo Huang, Chih‐Lang Lin, Mu‐Jie Lu, Chau‐Ting Yeh, Kung‐Hao Liang, Chi‐Chin Sun, Yu‐Chiau Shyu, Rong‐Nan Chien. Diabetes, hepatocellular carcinoma, and mortality in hepatitis C‐infected patients: A population‐based cohort studyJournal of Gastroenterology and Hepatology 2017; 32(7): 1355 doi: 10.1111/jgh.13670
31
Nicolas Goossens, Francesco Negro. Cardiovascular Manifestations of Hepatitis C VirusClinics in Liver Disease 2017; 21(3): 465 doi: 10.1016/j.cld.2017.03.003
32
Yannick Chibinda Birato, Tony Akilimali Shindano, Daudi Cinyabuuma, Ciza Abel, Cikomola Justin Chiruza, Andre N. H. Bulabula. Seroprevalence and associated risk factors of hepatitis C infection among diabetic patients in South‐Kivu, Eastern Democratic Republic of the Congo: A cross‐sectional studyHealth Science Reports 2023; 6(8) doi: 10.1002/hsr2.1504
33
Milind Y. Junghare, Hassan N. Ibrahim. Chronic Renal Disease2015; : 544 doi: 10.1016/B978-0-12-411602-3.00045-7
34
Tsutomu Nishida. Diagnosis and Clinical Implications of Diabetes in Liver Cirrhosis: A Focus on the Oral Glucose Tolerance TestJournal of the Endocrine Society 2017; 1(7): 886 doi: 10.1210/js.2017-00183
35
Z. Younossi, M. Stepanova, S. Saab, G. Trimble, A. Mishra, L. Henry. The association of hepatitis C virus infection and post‐liver transplant diabetes: data from 17 000 HCV‐infected transplant recipientsAlimentary Pharmacology & Therapeutics 2015; 41(2): 209 doi: 10.1111/apt.13027
36
Reza Taherkhani, Fatemeh Farshadpour. Epidemiology of hepatitis C virus in IranWorld Journal of Gastroenterology 2015; 21(38): 10790-10810 doi: 10.3748/wjg.v21.i38.10790
37
Marc G. Ghany, T. Jake Liang. Hepatitis C Virus II2016; : 3 doi: 10.1007/978-4-431-56101-9_1
38
Man Yuan, Juan Zhou, Lingyao Du, Libo Yan, Hong Tang. Hepatitis C Virus Clearance with Glucose Improvement and Factors Affecting the Glucose Control in Chronic Hepatitis C PatientsScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58786-x
39
Rowan Hillson. Viruses and diabetesPractical Diabetes 2016; 33(6): 190 doi: 10.1002/pdi.2034
40
Roaid Khan, Graham R. Foster, Tahseen A. Chowdhury. Managing Diabetes in Patients with Chronic Liver DiseasePostgraduate Medicine 2012; 124(4): 130 doi: 10.3810/pgm.2012.07.2574
41
Chang Hwi Yoon, Young-Joo Jin, Jin Woo Lee. Nonalcoholic fatty liver disease-associated hepatocellular carcinoma in a hepatitis B virus-endemic areaEuropean Journal of Gastroenterology & Hepatology 2018; 30(9): 1090 doi: 10.1097/MEG.0000000000001174
42
Khalid Siddiqui, Shivani Tyagi. Genetics, Genomics and Personalized Medicine in Type 2 Diabetes: A Perspective on the Arab RegionPersonalized Medicine 2015; 12(4): 417 doi: 10.2217/pme.15.11
43
Luis Calzadilla-Bertot, Eduardo Vilar-Gomez, Ana Torres-Gonzalez, Maray Socias-Lopez, Moises Diago, Leon A. Adams, Manuel Romero-Gomez. Impaired glucose metabolism increases risk of hepatic decompensation and death in patients with compensated hepatitis C virus-related cirrhosisDigestive and Liver Disease 2016; 48(3): 283 doi: 10.1016/j.dld.2015.12.002
44
Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo-Jack, Michael B. Davidson, Daniel Einhorn, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez, Michael H. Davidson. American Association of Clinical Endocrinologists’ Comprehensive Diabetes Management Algorithm 2013 Consensus StatementEndocrine Practice 2013; 19: 1 doi: 10.4158/EP13176.CSUPPL
45
Syed Haris Ahmed, Kathryn Biddle, Titus Augustine, Shazli Azmi. Post-Transplantation Diabetes MellitusDiabetes Therapy 2020; 11(4): 779 doi: 10.1007/s13300-020-00790-5
46
Mohamad S. Hakim, Xinying Zhou, Yijin Wang, Maikel P. Peppelenbosch, Qiuwei Pan. Anti-diabetic drugs, insulin and metformin, have no direct interaction with hepatitis C virus infection or anti-viral interferon responseAIMS Molecular Science 2014; 1(1): 49 doi: 10.3934/molsci.2014.1.49
47
Diego F. Cuadros, F. DeWolfe Miller, Nico Nagelkerke, Laith J. Abu-Raddad. Association between HCV infection and diabetes type 2 in Egypt: is it time to split up?Annals of Epidemiology 2015; 25(12): 918 doi: 10.1016/j.annepidem.2015.09.005
48
CUIXIA CAI, JUN ZENG, HUIHUI WU, RONG SHI, MIN WEI, YUAN GAO, WENLI MA. Association between hepatitis B virus infection and diabetes mellitus: A meta-analysisExperimental and Therapeutic Medicine 2015; 10(2): 693 doi: 10.3892/etm.2015.2537
49
Shereen Abdel Alem, Aisha Elsharkawy, Rabab Fouad, Eman Adel, Zeinab Abdellatif, Sherief Musa, Ahmed Nagy, Muhammad S. Hussein, Ayman Yosry, Gamal Esmat. Improvement of glycemic state among responders to Sofosbuvir‐based treatment regimens: Single center experienceJournal of Medical Virology 2017; 89(12): 2181 doi: 10.1002/jmv.24897
50
Kenneth Cusi. The relationship between hepatitis C virus infection and diabetes: Time for a divorce?Hepatology 2014; 60(4): 1121 doi: 10.1002/hep.27252
51
Olufunso O. Sogbanmu, Larry O. Obi, Daniel T. Goon, Anthony Okoh, Benson Iweriebor, Uchechukwu. U. Nwodo, Anthony I. Ajayi, Tennison O. Digban. Diagnosing Diabetes Mellitus With Glycated Haemoglobin in Newly Diagnosed HIV-positive Patients in Buffalo City Municipality, South Africa: A Cross-sectional StudyThe Open Public Health Journal 2019; 12(1): 263 doi: 10.2174/1874944501912010263
52
Rudruidee Karnchanasorn, Horng-Yih Ou, James Lin, Lee-Ming Chuang, Ken C. Chiu. Viral Hepatitis and Diabetes: Clinical Implications of Diabetes Prevention Through Hepatitis VaccinationCurrent Diabetes Reports 2016; 16(10) doi: 10.1007/s11892-016-0790-y
53
Debaka Belete, Dessie Kassaw, Tesfaye Andualem, Quirino Lai. Prevalence of Hepatitis B and Hepatitis C Viral Infections and Their Associated Factors among Diabetic Patients Visiting Debre Tabor Referral Hospital, Northwest Ethiopia, 2021: A Cross-Sectional StudyCanadian Journal of Gastroenterology and Hepatology 2023; 2023: 1 doi: 10.1155/2023/5077706
54
Muneerah Hamad Aldubaie, Prarthana M. Suryavamshi, Uma M. Irfan, Hamad A. Al-Hamed, Turki Abdullah Almogbel, Ahmad Almatroudi, Faris Alrumaihi, Khaled Allemailem. Prevalence of Hepatitis C Viral Infection among Diabetes Mellitus Patients in Qassim Region, Saudi ArabiaJournal of Pure and Applied Microbiology 2023; 17(3): 1722 doi: 10.22207/JPAM.17.3.37
55
V. V. Tsvetkov, I. I. Tokin, S. A. Pozdnjakova. Clinical epidemiology of extrahepatic manifestations of chronic hepatitis C virus infectionMedical Council 2020; (21): 248 doi: 10.21518/2079-701X-2019-21-248-253
56
Misbah Ul Qamar, Maria Gill, Faiza Ikram, Shaheena Naz, Hina Sadaf, Zobiah Hafeez. Insulin Resistance and Chronic Hepatitis C: Relationship With Serum Iron and HepcidinCureus 2020;  doi: 10.7759/cureus.12349
57
Felix M. Wensveen, Marko Šestan, Tamara Turk Wensveen, Bojan Polić. ‘Beauty and the beast’ in infection: How immune–endocrine interactions regulate systemic metabolism in the context of infectionEuropean Journal of Immunology 2019; 49(7): 982 doi: 10.1002/eji.201847895
58
Wangjun Zhang, Fan Xiao, Jie Li, Xiaoyu Guo, Zhitao Lin, Zijian Huang, Ning Mao, Bei Sun, Gang Wang. Rare heterochronous liver and pancreatic multiple primary cancers: a case report and literature reviewZeitschrift für Gastroenterologie 2020; 58(11): 1094 doi: 10.1055/a-1160-6082
59
Praveen Raman Mishra, Akash Bharti, Ridhi Arora, Irfan Ahmad Mir, V. P. S. Punia. Increased Insulin Resistance in Hepatitis-C Infection—Association with Altered Hepatic Function TestingPathophysiology 2022; 29(3): 326 doi: 10.3390/pathophysiology29030024
60
P. Pavone, T. Tieghi, G. d'Ettorre, M. Lichtner, R. Marocco, I. Mezzaroma, G. Passavanti, P. Vittozzi, C.M. Mastroianni, V. Vullo. Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agentsClinical Microbiology and Infection 2016; 22(5): 462.e1 doi: 10.1016/j.cmi.2015.12.030
61
Yun Soo Hong, Yoosoo Chang, Seungho Ryu, Miguel Cainzos-Achirica, Min-Jung Kwon, Yiyi Zhang, Yuni Choi, Jiin Ahn, Sanjay Rampal, Di Zhao, Roberto Pastor-Barriuso, Mariana Lazo, Hocheol Shin, Juhee Cho, Eliseo Guallar. Hepatitis B and C virus infection and diabetes mellitus: A cohort studyScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04206-6
62
Alessia Ciancio, Roberta Bosio, Simona Bo, Marianna Pellegrini, Marco Sacco, Edoardo Vogliotti, Giulia Fassio, Andrea G. F. Bianco Mauthe Degerfeld, Monica Gallo, Chiara Giordanino, Lodovico Terzi di Bergamo, Davide Ribaldone, Elisabetta Bugianesi, Antonina Smedile, Mario Rizzetto, Giorgio Maria Saracco. Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct‐acting antiviral agentsJournal of Medical Virology 2018; 90(2): 320 doi: 10.1002/jmv.24954
63
Alessia Ciancio, Davide G. Ribaldone, Anna Dotta, Chiara Giordanino, Marco Sacco, Sharmila Fagoonee, Rinaldo Pellicano, Giorgio M. Saracco. Long‐term follow‐up of diabetic and non‐diabetic patients with chronic hepatitis C successfully treated with direct‐acting antiviral agentsLiver International 2021; 41(2): 276 doi: 10.1111/liv.14676
64
Jun Lu, Xuhong Hou, Hong Tu, Zhenghao Tang, Yongbing Xiang, Yuqian Bao, Jianren Gu, Weiping Jia. Chronic hepatitis B virus infection status is more prevalent in patients with type 2 diabetesJournal of Diabetes Investigation 2017; 8(4): 619 doi: 10.1111/jdi.12609
65
Giorgio A. Roccaro, Robert Mitrani, Wei‐Ting Hwang, Kimberly A. Forde, K. Rajender Reddy. Sustained Virological Response Is Associated with a Decreased Risk of Posttransplant Diabetes Mellitus in Liver Transplant Recipients with Hepatitis C–Related Liver DiseaseLiver Transplantation 2018; 24(12): 1665 doi: 10.1002/lt.25351
66
Silvia Fabiani, Poupak Fallahi, Silvia Martina Ferrari, Mario Miccoli, Alessandro Antonelli. Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literatureReviews in Endocrine and Metabolic Disorders 2018; 19(4): 405 doi: 10.1007/s11154-017-9440-1
67
Cesare Mazzaro, Luca Quartuccio, Luigi Elio Adinolfi, Dario Roccatello, Gabriele Pozzato, Riccardo Nevola, Maurizio Tonizzo, Stefano Gitto, Pietro Andreone, Valter Gattei. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral TherapyViruses 2021; 13(11): 2249 doi: 10.3390/v13112249
68
Derong Sun, Wenqian Qi, Song Wang, Xu Wang, Yonggui Zhang, Jiangbin Wang. Genetic Polymorphism of CYP27B1-1260 as Associated With Impaired Fasting Glucose in Patients With Chronic Hepatitis C Undergoing Antiviral TherapyHepatitis Monthly 2016; 16(9) doi: 10.5812/hepatmon.35179
69
Sirio Fiorino, Letizia Bacchi-Reggiani, Dario de Biase, Adele Fornelli, Michele Masetti, Andrea Tura, Fabio Grizzi, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Giorgia Acquaviva, Luca di Tommaso, Arrigo Bondi, Michela Visani, Sergio Sabbatani, Laura Pontoriero, Carlo Fabbri, Andrea Cuppini, Annalisa Pession, Elio Jovine. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic reviewWorld Journal of Gastroenterology 2015; 21(45): 12896-12953 doi: 10.3748/wjg.v21.i45.12896
70
Roy Hall, Leigh Owens, Brenda Govan, Marie Caltabiano, Paula Clancy, Alanna Sorenson, Yvonne Cadet-James. The Impact of Prior Flavivirus Infections on the Development of Type 2 Diabetes Among the Indigenous AustraliansThe American Journal of Tropical Medicine and Hygiene 2016; 95(2): 265 doi: 10.4269/ajtmh.15-0727
71
Trevor A. Crowell, Kelly A. Gebo, Ashwin Balagopal, John A. Fleishman, Allison L. Agwu, Stephen A. Berry. Impact of Hepatitis Coinfection on Hospitalization Rates and Causes in a Multicenter Cohort of Persons Living With HIVJAIDS Journal of Acquired Immune Deficiency Syndromes 2014; 65(4): 429 doi: 10.1097/QAI.0000000000000059
72
Eric Lontchi-Yimagou, Charly Feutseu, Sebastien Kenmoe, Alexandra Lindsey Djomkam Zune, Solange Fai Kinyuy Ekali, Jean Louis Nguewa, Siméon Pierre Choukem, Jean Claude Mbanya, Jean Francois Gautier, Eugene Sobngwi. Non-autoimmune diabetes mellitus and the risk of virus infections: a systematic review and meta-analysis of case-control and cohort studiesScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-88598-6
73
Clarissa Cordeiro Alves Arrelias, Fernando Belissimo Rodrigues, Maria Teresa da Costa Gonçalves Torquato, Carla Regina de Souza Teixeira, Flávia Fernanda Luchetti Rodrigues, Maria Lucia Zanetti. Prevalence of serological markers for hepatitis and potential associated factors in patients with diabetes mellitusRevista Latino-Americana de Enfermagem 2018; 26(0) doi: 10.1590/1518-8345.2774.3085
74
Jing Liang, Chaoyang Lv, Minling Chen, Ming Xu, Chenhe Zhao, Yinqiu Yang, Jina Wang, Dong Zhu, Jian Gao, Ruiming Rong, Tongyu Zhu, Mingxiang Yu. Effects of preoperative hepatitis B virus infection, hepatitis C virus infection, and coinfection on the development of new‐onset diabetes after kidney transplantationJournal of Diabetes 2019; 11(5): 370 doi: 10.1111/1753-0407.12853
75
Vijay Shivaswamy, Brian Boerner, Jennifer Larsen. Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on OutcomesEndocrine Reviews 2016; 37(1): 37 doi: 10.1210/er.2015-1084
76
Carla Carnovale, Marco Pozzi, Alice Dassano, Francesca D’Addio, Marta Gentili, Carlo Magni, Emilio Clementi, Sonia Radice, Paolo Fiorina. The impact of a successful treatment of hepatitis C virus on glyco-metabolic control in diabetic patients: a systematic review and meta-analysisActa Diabetologica 2019; 56(3): 341 doi: 10.1007/s00592-018-1257-1
77
Naim Abu Freha, Tamar Wainstock, Tzvi Najman Menachem, Eyal Sheiner. Maternal Hepatitis B Virus or Hepatitis C Virus Carrier Status and Long-Term Endocrine Morbidity of the Offspring—A Population-Based Cohort StudyJournal of Clinical Medicine 2020; 9(3): 796 doi: 10.3390/jcm9030796
78
Shazia Hussain, Tahseen A. Chowdhury. The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes MellitusDrugs 2019; 79(3): 231 doi: 10.1007/s40265-019-1061-4
79
Gautam Das, Hemanth Bolusani. Hepatitis C virus infection and diabetesPractical Diabetes 2016; 33(4): 123 doi: 10.1002/pdi.2017
80
Yu-Cheng Cheng, Teng-Yu Lee, Yu-Hsuan Li, Chin-Li Lu, Hsiu-Chen Liu, Meei Ling Sheu, I-Te Lee. Hepatitis C virus antibody seropositivity is associated with albuminuria but not peripheral artery disease in patients with type 2 diabetesScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-55352-7
81
P. A. Beliy, K. R. Dudina, O. O. Znoyko, T. N. Markova, I. A. Morozova, N. P. Blokhina, E. A. Nurmukhametova, N. D. Yushchuk. Prevalence of chronic HCV infection in patients with type 2 diabetes mellitus in RussiaDiabetes mellitus 2022; 25(1): 4 doi: 10.14341/DM12847
82
Elham Sayed Marei, Hanan Mohamed Gabr, Dina Sami Shaheen. Potential role of vaspin and apelin in chronic hepatitis C virus patients with and without diabetesJournal of Radiation Research and Applied Sciences 2020; 13(1): 155 doi: 10.1080/16878507.2020.1715556
83
Davis Kibirige, Richard Ssekitoleko, Edrisa Mutebi, William Worodria. Overt diabetes mellitus among newly diagnosed Ugandan tuberculosis patients: a cross sectional studyBMC Infectious Diseases 2013; 13(1) doi: 10.1186/1471-2334-13-122
84
Taiba Zornitzki, Stephen Malnick, Lyudmila Lysyy, Hilla Knobler. Interferon therapy in hepatitis C leading to chronic type 1 diabetesWorld Journal of Gastroenterology 2015; 21(1): 233-239 doi: 10.3748/wjg.v21.i1.233
85
Simone Lanini, Paola Scognamiglio, Raffaella Pisapia, Claudia Minosse, Alessandro Agresta, Giuseppe Ippolito. Recovery of metabolic impairment in patients who cleared chronic hepatitis C infection after direct-acting antiviral therapyInternational Journal of Antimicrobial Agents 2019; 53(5): 559 doi: 10.1016/j.ijantimicag.2018.11.024
86
R. Mahajan, J. Xing, S. J. Liu, K. N. Ly, A. C. Moorman, L. Rupp, F. Xu, S. D. Holmberg, S. D. Holmberg, E. H. Teshale, P. R. Spradling, A. C. Moorman, S. C. Gordon, D. R. Nerenz, M. Lu, L. Lamerato, L. B. Rupp, N. Akkerman, N. Oja-Tebbe, C. M. Cogan, D. Larkin, J. A. Boscarino, Z. S. Daar, J. B. Leader, R. E. Smith, C. C. Nakasato, V. Vijayadeva, K. E. Sylva, J. V. Parker, M. M. Schmidt, M. A. Schmidt, J. L. Donald, E. M. Keast. Mortality Among Persons in Care With Hepatitis C Virus Infection: The Chronic Hepatitis Cohort Study (CHeCS), 2006-2010Clinical Infectious Diseases 2014; 58(8): 1055 doi: 10.1093/cid/ciu077
87
Julia M. Grottenthaler, Judith K. Füger, Moritz Mahling, Alfred Königsrainer, Nisar P. Malek, Andreas L. Birkenfeld, Silvio Nadalin, Christoph P. Berg, Nils Heyne, Martina Guthoff. Dynamics of glucose metabolism after liver transplantation: prediabetes as a window of opportunity for patient survival and long‐term kidney functionTransplant International 2021; 34(10): 1959 doi: 10.1111/tri.13967
88
Trevor A. Crowell, Stephen A. Berry, John A. Fleishman, Richard W. LaRue, Philip T. Korthuis, Ank E. Nijhawan, Richard D. Moore, Kelly A. Gebo. Impact of Hepatitis Coinfection on Healthcare Utilization Among Persons Living With HIVJAIDS Journal of Acquired Immune Deficiency Syndromes 2015; 68(4): 425 doi: 10.1097/QAI.0000000000000490
89
Alaaeldin Abdelsalam Dawood, Mohamed Zakarya Nooh, Ayman Abdelhaleem Elgamal. Factors Associated with Improved Glycemic Control by Direct-Acting Antiviral Agent Treatment in Egyptian Type 2 Diabetes Mellitus Patients with Chronic Hepatitis C Genotype 4Diabetes & Metabolism Journal 2017; 41(4): 316 doi: 10.4093/dmj.2017.41.4.316
90
Akira Matsumori. Novel Biomarkers of Inflammation for the Management of Diabetes: Immunoglobulin-Free Light ChainsBiomedicines 2022; 10(3): 666 doi: 10.3390/biomedicines10030666
91
Riccardo NEVOLA, Carlo ACIERNO, Pia C. PAFUNDI, Luigi E. ADINOLFI. Chronic hepatitis C infection induces cardiovascular disease and type 2 diabetes: mechanisms and managementMinerva Medica 2021; 112(2) doi: 10.23736/S0026-4806.20.07129-3
92
Davide Giuseppe Ribaldone, Marco Sacco, Giorgio Maria Saracco. The Effect of Viral Clearance Achieved by Direct-Acting Antiviral Agents on Hepatitis C Virus Positive Patients with Type 2 Diabetes Mellitus: A Word of Caution after the Initial EnthusiasmJournal of Clinical Medicine 2020; 9(2): 563 doi: 10.3390/jcm9020563
93
Elenjickal Elias John, Sudhir Mehta, Preet Mohinder Sohal, Jasvinder Singh Sandhu. Predictors of Short-Term Outcomes in Living Donor Renal Allograft Recipients: A Prospective Study From a Tertiary Care Center in North IndiaCureus 2022;  doi: 10.7759/cureus.28335
94
M. Hecking, J. Werzowa, M. Haidinger, W. H. Horl, J. Pascual, K. Budde, F. L. Luan, A. Ojo, A. P. J. de Vries, E. Porrini, G. Pacini, F. K. Port, A. Sharif, M. D. Saemann. Novel views on new-onset diabetes after transplantation: development, prevention and treatmentNephrology Dialysis Transplantation 2013; 28(3): 550 doi: 10.1093/ndt/gfs583
95
Jian Zhang, Yi Shen, Hui Cai, Yan‐Mei Liu, Gang Qin. Hepatitis B virus infection status and risk of type 2 diabetes mellitus: A meta‐analysisHepatology Research 2015; 45(11): 1100 doi: 10.1111/hepr.12481
96
James Yue Zhang, Curtis Cooper, Mary-Anne Doyle. Association between hepatitis C antiviral treatment and diabetes mellitus: A case seriesOfficial Journal of the Association of Medical Microbiology and Infectious Disease Canada 2020; 5(2): 104 doi: 10.3138/jammi-2019-0007
97
Samia T. Ali, Nagwa A. Mohamed. Inadequate serum hepcidin levels in chronic hepatitis C infection-induced type 2 diabetes mellitusThe Scientific Journal of Al-Azhar Medical Faculty, Girls 2019; 3(1): 91 doi: 10.4103/sjamf.sjamf_59_18
98
Constance E. Ruhl, Andy Menke, Catherine C. Cowie, James E. Everhart. Relationship of hepatitis C virus infection with diabetes in the U.S. populationHepatology 2014; 60(4): 1139 doi: 10.1002/hep.27047
99
Shilpa Lingala, Marc G. Ghany. Natural History of Hepatitis CGastroenterology Clinics of North America 2015; 44(4): 717 doi: 10.1016/j.gtc.2015.07.003
100
Hilla Knobler, Stephen Malnick. Hepatitis C and insulin action: An intimate relationshipWorld Journal of Hepatology 2016; 8(2): 131-138 doi: 10.4254/wjh.v8.i2.131
101
Javier Ampuero, Manuel Romero-Gomez. Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metforminWorld Journal of Hepatology 2015; 7(8): 1105-1111 doi: 10.4254/wjh.v7.i8.1105
102
Alaaeldin M.K. Bashier, Dileep Kumar, Fakhriya J. Alalawi, Hind Al Nour, Amna Khalifa Al Hadari, Azza Abdulaziz Bin Hussain. Post-Transplant Diabetes: Prevalence, Risk, and Management ChallengesDubai Diabetes and Endocrinology Journal 2022; 28(3): 79 doi: 10.1159/000522092
103
H. Y. Choi, Y. Kim, H. Cho, B. H. Kim, M. Ki. Risk of diabetes in viral hepatitis B or C patients compared to that in noninfected individuals in Korea, 2002‐2013: A population‐based cohort studyJournal of Viral Hepatitis 2018; 25(3): 272 doi: 10.1111/jvh.12815
104
Xuan Guo, Min Jin, Ming Yang, Ke Liu, Jun-wen Li. Type 2 Diabetes Mellitus and the Risk of Hepatitis C Virus Infection: A systematic reviewScientific Reports 2013; 3(1) doi: 10.1038/srep02981
105
Ahmad Nawaz, Javeria Kiran, Amina Zafar, Shahroz Alam, Muhammad Amjad Bashir, Munaza Batool, Sagheer Atta, Mamoona Noreen, Muhammad Yousaf Ali, Khizar Samiullah, Riffat Yasin, Mahroz Fazal, Wadi B. Alonazi, Awais Amjad, Safdar Hussain, Umair Khurshid, Muhammad Essa. A study on causes and community response regarding diabetes as a community disease of southern Punjab PakistanJournal of King Saud University - Science 2023; 35(3): 102519 doi: 10.1016/j.jksus.2022.102519
106
Sintayehu Ambachew, Setegn Eshetie, Demeke Geremew, Aklilu Endalamaw, Mulugeta Melku. Prevalence of Type 2 Diabetes Mellitus among Hepatitis C Virus-Infected Patients: A Systematic Review and Meta-AnalysisDubai Diabetes and Endocrinology Journal 2018; 24(1-4): 29 doi: 10.1159/000493945
107
Shih Ping Lin, Chun-Ying Wu, Chang-Bi Wang, Tsai-Chung Li, Nai-Ying Ko, Zhi-Yuan Shi. Risk of diabetes mellitus in HIV-infected patients receiving highly active antiretroviral therapyMedicine 2018; 97(36): e12268 doi: 10.1097/MD.0000000000012268
108
Kathy K. Byrd, Jason M. Mehal, Sarah F. Schillie, Robert C. Holman, Dana Haberling, Trudy Murphy. Chronic Liver Disease-Associated Hospitalizations among Adults with Diabetes, National Inpatient Sample, 2001–2012Public Health Reports 2015; 130(6): 693 doi: 10.1177/003335491513000619
109
Marco SACCO, Giorgio M. SARACCO. The impact of direct-acting antiviral treatment on glycemic homeostasis in patients with chronic hepatitis CMinerva Gastroenterology 2021; 67(3) doi: 10.23736/S2724-5985.21.02835-X
110
Dibya L. Praharaj, Anil C. Anand. Nutrition in Viral HepatitisCurrent Hepatology Reports 2023; 22(1): 9 doi: 10.1007/s11901-023-00596-6
111
S.Sukumaran Nair, H.A. Chakkera. Effect of HCV, HIV and Coinfection in Kidney Transplant Recipients: Mate Kidney Analyses: The Role of DiabetesAmerican Journal of Transplantation 2015; 15(3): 846 doi: 10.1111/ajt.13078